Annual CAPEX
$3.81 B
+$894.41 M+30.67%
December 1, 2024
Summary
- As of February 23, 2025, GSK annual capital expenditures is $3.81 billion, with the most recent change of +$894.41 million (+30.67%) on December 1, 2024.
- During the last 3 years, GSK annual CAPEX has risen by +$159.89 million (+4.38%).
- GSK annual CAPEX is now -11.22% below its all-time high of $4.29 billion, reached on December 31, 2007.
Performance
GSK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$1.41 B
+$272.38 M+23.99%
December 1, 2024
Summary
- As of February 23, 2025, GSK quarterly capital expenditures is $1.41 billion, with the most recent change of +$272.38 million (+23.99%) on December 1, 2024.
- Over the past year, GSK quarterly CAPEX has stayed the same.
- GSK quarterly CAPEX is now -15.80% below its all-time high of $1.67 billion, reached on December 31, 2000.
Performance
GSK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$3.81 B
+$467.68 M+13.99%
December 1, 2024
Summary
- As of February 23, 2025, GSK TTM capital expenditures is $3.81 billion, with the most recent change of +$467.68 million (+13.99%) on December 1, 2024.
- Over the past year, GSK TTM CAPEX has stayed the same.
- GSK TTM CAPEX is now -11.22% below its all-time high of $4.29 billion, reached on December 31, 2007.
Performance
GSK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
GSK CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.7% | 0.0% | 0.0% |
| 3 y3 years | +4.4% | 0.0% | 0.0% |
| 5 y5 years | +38.0% | 0.0% | 0.0% |
GSK CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.3% | at high | +191.8% | -3.0% | +51.3% |
| 5 y | 5-year | at high | +52.7% | -13.9% | +219.3% | -3.0% | +53.7% |
| alltime | all time | -11.2% | +508.5% | -15.8% | +650.4% | -11.2% | -100.0% |
GSK CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.81 B(+30.7%) | $1.41 B(+24.0%) | $3.81 B(+14.0%) |
| Sep 2024 | - | $1.14 B(+105.0%) | $3.34 B(+17.2%) |
| Jun 2024 | - | $553.89 M(-22.4%) | $2.85 B(-4.5%) |
| Mar 2024 | - | $714.10 M(-24.0%) | $2.99 B(+2.4%) |
| Dec 2023 | $2.92 B(+4.3%) | $940.06 M(+45.8%) | $2.92 B(-2.7%) |
| Sep 2023 | - | $644.85 M(-6.4%) | $3.00 B(+5.7%) |
| Jun 2023 | - | $688.78 M(+7.1%) | $2.84 B(+6.1%) |
| Mar 2023 | - | $643.00 M(-37.1%) | $2.67 B(-4.4%) |
| Dec 2022 | $2.80 B(-23.4%) | $1.02 B(+111.9%) | $2.80 B(+11.0%) |
| Sep 2022 | - | $482.52 M(-8.3%) | $2.52 B(-31.4%) |
| Jun 2022 | - | $526.35 M(-31.2%) | $3.67 B(-6.5%) |
| Mar 2022 | - | $764.75 M(+2.5%) | $3.93 B(+7.6%) |
| Dec 2021 | $3.65 B(+46.3%) | $746.13 M(-54.4%) | $3.65 B(+1.4%) |
| Sep 2021 | - | $1.64 B(+109.4%) | $3.60 B(+26.7%) |
| Jun 2021 | - | $781.18 M(+60.1%) | $2.84 B(+11.7%) |
| Mar 2021 | - | $487.99 M(-29.8%) | $2.54 B(+1.9%) |
| Dec 2020 | $2.50 B(-9.6%) | $694.93 M(-20.7%) | $2.50 B(-12.1%) |
| Sep 2020 | - | $876.27 M(+81.0%) | $2.84 B(+14.5%) |
| Jun 2020 | - | $484.21 M(+9.8%) | $2.48 B(-11.6%) |
| Mar 2020 | - | $440.91 M(-57.6%) | $2.81 B(+1.6%) |
| Dec 2019 | $2.76 B(+15.3%) | $1.04 B(+101.5%) | $2.76 B(+6.0%) |
| Sep 2019 | - | $515.77 M(-36.4%) | $2.61 B(-0.1%) |
| Jun 2019 | - | $810.75 M(+104.7%) | $2.61 B(+13.5%) |
| Mar 2019 | - | $396.03 M(-55.2%) | $2.30 B(-4.1%) |
| Dec 2018 | $2.40 B(-15.7%) | $883.95 M(+70.8%) | $2.40 B(+1.5%) |
| Sep 2018 | - | $517.57 M(+3.3%) | $2.36 B(-6.5%) |
| Jun 2018 | - | $501.15 M(+1.5%) | $2.52 B(-10.6%) |
| Mar 2018 | - | $493.63 M(-41.8%) | $2.82 B(-0.8%) |
| Dec 2017 | $2.84 B(-10.8%) | $848.19 M(+24.6%) | $2.84 B(-8.0%) |
| Sep 2017 | - | $680.84 M(-14.8%) | $3.09 B(+5.7%) |
| Jun 2017 | - | $798.89 M(+55.1%) | $2.93 B(+3.9%) |
| Mar 2017 | - | $515.23 M(-53.0%) | $2.82 B(-11.6%) |
| Dec 2016 | $3.19 B(+9.7%) | $1.10 B(+112.8%) | $3.19 B(+2.8%) |
| Sep 2016 | - | $515.48 M(-25.1%) | $3.10 B(-5.6%) |
| Jun 2016 | - | $688.23 M(-22.3%) | $3.28 B(+1.4%) |
| Mar 2016 | - | $886.11 M(-12.3%) | $3.24 B(+11.5%) |
| Dec 2015 | $2.91 B(+0.7%) | $1.01 B(+44.2%) | $2.91 B(+2.4%) |
| Sep 2015 | - | $700.35 M(+9.2%) | $2.84 B(+0.2%) |
| Jun 2015 | - | $641.51 M(+16.0%) | $2.83 B(-1.1%) |
| Mar 2015 | - | $553.26 M(-41.2%) | $2.86 B(-0.8%) |
| Dec 2014 | $2.89 B(+8.5%) | $941.27 M(+35.5%) | $2.89 B(+5.2%) |
| Sep 2014 | - | $694.66 M(+3.2%) | $2.74 B(-1.0%) |
| Jun 2014 | - | $672.92 M(+16.5%) | $2.77 B(+0.9%) |
| Mar 2014 | - | $577.45 M(-27.7%) | $2.75 B(+3.2%) |
| Dec 2013 | $2.66 B(+10.5%) | $799.02 M(+10.6%) | $2.66 B(-1.3%) |
| Sep 2013 | - | $722.61 M(+11.6%) | $2.70 B(+4.7%) |
| Jun 2013 | - | $647.30 M(+31.5%) | $2.58 B(+3.0%) |
| Mar 2013 | - | $492.42 M(-41.0%) | $2.50 B(+3.8%) |
| Dec 2012 | $2.41 B(+13.1%) | $834.34 M(+38.5%) | $2.41 B(+4.1%) |
| Sep 2012 | - | $602.29 M(+5.4%) | $2.31 B(+7.1%) |
| Jun 2012 | - | $571.43 M(+42.7%) | $2.16 B(+3.0%) |
| Mar 2012 | - | $400.54 M(-45.9%) | $2.10 B(-1.4%) |
| Dec 2011 | $2.13 B | $739.89 M(+64.5%) | $2.13 B(+3.0%) |
| Sep 2011 | - | $449.88 M(-11.6%) | $2.07 B(-15.9%) |
| Jun 2011 | - | $508.79 M(+18.1%) | $2.46 B(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $430.92 M(-36.5%) | $2.44 B(-3.1%) |
| Dec 2010 | $2.52 B(-14.1%) | $678.72 M(-19.2%) | $2.52 B(-8.5%) |
| Sep 2010 | - | $840.10 M(+70.3%) | $2.75 B(+5.3%) |
| Jun 2010 | - | $493.38 M(-2.9%) | $2.61 B(-9.3%) |
| Mar 2010 | - | $508.34 M(-44.3%) | $2.88 B(-1.7%) |
| Dec 2009 | $2.93 B(-23.3%) | $913.03 M(+30.4%) | $2.93 B(-14.2%) |
| Sep 2009 | - | $700.24 M(-8.2%) | $3.42 B(-5.2%) |
| Jun 2009 | - | $762.90 M(+36.8%) | $3.61 B(-4.1%) |
| Mar 2009 | - | $557.64 M(-60.1%) | $3.76 B(-1.7%) |
| Dec 2008 | $3.83 B(-10.9%) | $1.40 B(+57.6%) | $3.83 B(+5.7%) |
| Sep 2008 | - | $887.39 M(-3.2%) | $3.62 B(-0.3%) |
| Jun 2008 | - | $917.08 M(+47.2%) | $3.63 B(+2.8%) |
| Mar 2008 | - | $622.91 M(-47.8%) | $3.53 B(-17.7%) |
| Dec 2007 | $4.29 B(+46.5%) | $1.19 B(+33.2%) | $4.29 B(+5.8%) |
| Sep 2007 | - | $896.61 M(+9.6%) | $4.06 B(+1.0%) |
| Jun 2007 | - | $818.35 M(-40.9%) | $4.02 B(+2.8%) |
| Mar 2007 | - | $1.38 B(+44.3%) | $3.91 B(+33.4%) |
| Dec 2006 | $2.93 B(+36.4%) | $959.27 M(+12.0%) | $2.93 B(+4.7%) |
| Sep 2006 | - | $856.56 M(+20.6%) | $2.80 B(+17.0%) |
| Jun 2006 | - | $710.06 M(+75.6%) | $2.39 B(+8.2%) |
| Mar 2006 | - | $404.42 M(-51.1%) | $2.21 B(+2.9%) |
| Dec 2005 | $2.15 B(+12.4%) | $827.88 M(+84.2%) | $2.15 B(-7.1%) |
| Sep 2005 | - | $449.49 M(-15.0%) | $2.31 B(+10.6%) |
| Jun 2005 | - | $528.97 M(+54.6%) | $2.09 B(+5.1%) |
| Mar 2005 | - | $342.26 M(-65.5%) | $1.99 B(+4.1%) |
| Dec 2004 | $1.91 B(+34.6%) | $992.14 M(+337.0%) | $1.91 B(+47.9%) |
| Sep 2004 | - | $227.04 M(-46.9%) | $1.29 B(-12.2%) |
| Jun 2004 | - | $427.43 M(+61.6%) | $1.47 B(+2.3%) |
| Mar 2004 | - | $264.54 M(-29.1%) | $1.44 B(+1.4%) |
| Dec 2003 | $1.42 B(-23.0%) | $373.06 M(-8.2%) | $1.42 B(-16.9%) |
| Sep 2003 | - | $406.57 M(+3.0%) | $1.71 B(-2.5%) |
| Jun 2003 | - | $394.82 M(+61.1%) | $1.75 B(-2.1%) |
| Mar 2003 | - | $245.05 M(-63.0%) | $1.79 B(-2.8%) |
| Dec 2002 | $1.84 B(+14.4%) | $661.89 M(+46.8%) | $1.84 B(+8.4%) |
| Sep 2002 | - | $450.87 M(+4.1%) | $1.70 B(+1.8%) |
| Jun 2002 | - | $433.06 M(+46.0%) | $1.67 B(+8.5%) |
| Mar 2002 | - | $296.68 M(-42.9%) | $1.54 B(-4.3%) |
| Dec 2001 | $1.61 B(-3.7%) | $519.81 M(+23.5%) | $1.61 B(-41.7%) |
| Sep 2001 | - | $420.80 M(+39.0%) | $2.76 B(+32.4%) |
| Jun 2001 | - | $302.81 M(-17.4%) | $2.09 B(+26.9%) |
| Mar 2001 | - | $366.47 M(-78.1%) | $1.64 B(-1.7%) |
| Dec 2000 | $1.67 B(+73.1%) | $1.67 B(-753.6%) | $1.67 B(>+9900.0%) |
| Sep 2000 | - | -$255.77 M(+83.7%) | $0.00(-100.0%) |
| Jun 2000 | - | -$139.20 M(-135.2%) | $255.77 M(-35.2%) |
| Mar 2000 | - | $394.97 M | $394.97 M |
| Dec 1999 | $966.02 M(+22.7%) | - | - |
| Dec 1998 | $787.27 M(+15.8%) | - | - |
| Dec 1997 | $679.87 M(+8.5%) | - | - |
| Dec 1996 | $626.32 M(-42.0%) | - | - |
| Dec 1995 | $1.08 B(+40.9%) | - | - |
| Jun 1995 | $766.34 M(-11.0%) | - | - |
| Jun 1994 | $860.59 M(-12.9%) | - | - |
| Jun 1993 | $988.27 M(-5.4%) | - | - |
| Jun 1992 | $1.04 B(-7.1%) | - | - |
| Jun 1991 | $1.12 B | - | - |
FAQ
- What is GSK annual capital expenditures?
- What is the all time high annual CAPEX for GSK?
- What is GSK annual CAPEX year-on-year change?
- What is GSK quarterly capital expenditures?
- What is the all time high quarterly CAPEX for GSK?
- What is GSK quarterly CAPEX year-on-year change?
- What is GSK TTM capital expenditures?
- What is the all time high TTM CAPEX for GSK?
- What is GSK TTM CAPEX year-on-year change?
What is GSK annual capital expenditures?
The current annual CAPEX of GSK is $3.81 B
What is the all time high annual CAPEX for GSK?
GSK all-time high annual capital expenditures is $4.29 B
What is GSK annual CAPEX year-on-year change?
Over the past year, GSK annual capital expenditures has changed by +$894.41 M (+30.67%)
What is GSK quarterly capital expenditures?
The current quarterly CAPEX of GSK is $1.41 B
What is the all time high quarterly CAPEX for GSK?
GSK all-time high quarterly capital expenditures is $1.67 B
What is GSK quarterly CAPEX year-on-year change?
Over the past year, GSK quarterly capital expenditures has changed by $0.00 (0.00%)
What is GSK TTM capital expenditures?
The current TTM CAPEX of GSK is $3.81 B
What is the all time high TTM CAPEX for GSK?
GSK all-time high TTM capital expenditures is $4.29 B
What is GSK TTM CAPEX year-on-year change?
Over the past year, GSK TTM capital expenditures has changed by $0.00 (0.00%)